相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Human Anti-CD40 Antibody and Poly IC:LC Adjuvant Combination Induces Potent T Cell Responses in the Lung of Nonhuman Primates
Elizabeth A. Thompson et al.
JOURNAL OF IMMUNOLOGY (2015)
STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade
Juan Fu et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Synergistic antitumor activity of the CD122-biased immunostimulatory cytokine NKTR-214 when combined with anti-PD-1 in murine tumor models
Addepalli Murali et al.
Journal for ImmunoTherapy of Cancer (2015)
Vaccine adjuvant uses of poly-IC and derivatives
Karen Ao Martins et al.
EXPERT REVIEW OF VACCINES (2015)
Mechanisms and Functions of Inflammasomes
Mohamed Lamkanfi et al.
CELL (2014)
STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
Seng-Ryong Woo et al.
IMMUNITY (2014)
Therapeutic vaccines for cancer: an overview of clinical trials
Ignacio Melero et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Antigenic peptide nanofibers elicit adjuvant-free CD8+ T cell responses
Charles B. Chesson et al.
VACCINE (2014)
Dendritic cell subsets require cis-activation for cytotoxic CD8 T-cell induction
A. Nicole Desch et al.
NATURE COMMUNICATIONS (2014)
Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand-Peptide Conjugates
Gijs G. Zom et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
Jaikumar Duraiswamy et al.
CANCER RESEARCH (2013)
A Randomized Phase II Trial of Multiepitope Vaccination with Melanoma Peptides for Cytotoxic T Cells and Helper T Cells for Patients with Metastatic Melanoma (E1602)
Craig L. Slingluff et al.
CLINICAL CANCER RESEARCH (2013)
Particle platforms for cancer immunotherapy
Rita Elena Serda
INTERNATIONAL JOURNAL OF NANOMEDICINE (2013)
Human IL-2 Mutein with Higher Antitumor Efficacy Than Wild Type IL-2
Tania Carmenate et al.
JOURNAL OF IMMUNOLOGY (2013)
Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
Satoshi Wada et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
Yared Hailemichael et al.
NATURE MEDICINE (2013)
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Lijun Sun et al.
SCIENCE (2013)
Extremely potent immunotherapeutic activity of a STING agonist in the B16 melanoma model in vivo
Leticia Corrales et al.
Journal for ImmunoTherapy of Cancer (2013)
Modulating Adaptive Immune Responses to Peptide Self-Assemblies
Jai S. Rudra et al.
ACS NANO (2012)
TLR8: the forgotten relative revindicated
Jorge L. Cervantes et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2012)
Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients
Paul Sabbatini et al.
CLINICAL CANCER RESEARCH (2012)
PEGylation of Proteins and Liposomes: a Powerful and Flexible Strategy to Improve the Drug Delivery
Paola Milla et al.
CURRENT DRUG METABOLISM (2012)
Vaccination-induced functional competence of circulating human tumor-specific CD8 T-cells
Petra Baumgaertner et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
Steffen Walter et al.
NATURE MEDICINE (2012)
Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity
Taro Kawai et al.
IMMUNITY (2011)
Adjuvants for Enhancing the Immunogenicity of Whole Tumor Cell Vaccines
Cheryl Lai-Lai Chiang et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2011)
Randomized Multicenter Trial of the Effects of Melanoma-Associated Helper Peptides and Cyclophosphamide on the Immunogenicity of a Multipeptide Melanoma Vaccine
Craig L. Slingluff et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Vaccination With Patient-Specific Tumor-Derived Antigen in First Remission Improves Disease-Free Survival in Follicular Lymphoma
Stephen J. Schuster et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Duration of Antigen Availability Influences the Expansion and Memory Differentiation of T Cells
David A. Blair et al.
JOURNAL OF IMMUNOLOGY (2011)
gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
Douglas J. Schwartzentruber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia
S. Daayana et al.
BRITISH JOURNAL OF CANCER (2010)
CD4+ T-Cell Help in the Tumor Milieu Is Required for Recruitment and Cytolytic Function of CD8+ T Lymphocytes
Rinke Bos et al.
CANCER RESEARCH (2010)
K562/GM-CSF Immunotherapy Reduces Tumor Burden in Chronic Myeloid Leukemia Patients with Residual Disease on Imatinib Mesylate
B. Douglas Smith et al.
CLINICAL CANCER RESEARCH (2010)
Lympho-geographical concepts in vaccine delivery
Pal Johansen et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8α+ dendritic cells
Lionel Franz Poulin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
FDA Drug Approval Summary: Bevacizumab plus Interferon for Advanced Renal Cell Carcinoma
Jeff Summers et al.
ONCOLOGIST (2010)
A self-assembling peptide acting as an immune adjuvant
Jai S. Rudra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells
Carsten Krieg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
Michael A. Curran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Multiple innate signaling pathways cooperate with CD40 to induce potent, CD70-dependent cellular immunity
Jennifer A. McWilliams et al.
VACCINE (2010)
Clinical Use of Interferon-gamma
Catriona H. T. Miller et al.
CYTOKINE THERAPIES: NOVEL APPROACHES FOR CLINICAL INDICATIONS (2009)
IFN-α Enhances Peptide Vaccine-Induced CD8+ T Cell Numbers, Effector Function, and Antitumor Activity
Andrew G. Sikora et al.
JOURNAL OF IMMUNOLOGY (2009)
The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response
Rama S. Akondy et al.
JOURNAL OF IMMUNOLOGY (2009)
Infection-mimicking materials to program dendritic cells in situ
Omar A. Ali et al.
NATURE MATERIALS (2009)
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia.
Gemma G. Kenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome
Fiona A. Sharp et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Novel Multi-Peptide Vaccination In Hla-A2+Hormone Sensitive Patients With Biochemical Relapse of Prostate Cancer
Susan Feyerabend et al.
PROSTATE (2009)
Signalling through C-type lectin receptors: shaping immune responses
Teunis B. H. Geijtenbeek et al.
NATURE REVIEWS IMMUNOLOGY (2009)
CpG oligodeoxynucleotides alter lymphocyte and dendritic cell trafficking in humans
W. Nicholas Haining et al.
CLINICAL CANCER RESEARCH (2008)
Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation
Martijn S. Bijker et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: Results from a prospectively designed analysis of progression-free survival
David S. Alberts et al.
GYNECOLOGIC ONCOLOGY (2008)
Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant
Sylvia Adams et al.
JOURNAL OF IMMUNOLOGY (2008)
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Stephanie C. Eisenbarth et al.
NATURE (2008)
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
Hiroki Ishikawa et al.
NATURE (2008)
Immunotherapy of established (pre) malignant disease by synthetic long peptide vaccines
Cornelis J. M. Melief et al.
NATURE REVIEWS CANCER (2008)
Intracellular NOD-like receptors in host Defense and disease
Thirumala-Devi Kanneganti et al.
IMMUNITY (2007)
GlaxoSmithKline Adjuvant systems in vaccines: concepts, achievements and perspectives
Nathalie Garcon et al.
EXPERT REVIEW OF VACCINES (2007)
MFG-E8-mediated uptake of apoptotic cells by APCs links the pro- and antiinflammatory activities of GM-CSF
Masahisa Jinushi et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming
Danila Valmori et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Multiple CD4 and CD8 T-cell activation parameters predict vaccine efficacy in vivo mediated by individual DC-activating agonists
Marij J. P. Welters et al.
VACCINE (2007)
Combined TLR/CD40 stimulation mediates potent cellular immunity by regulating dendritic cell expression of CD70 in vivo
Phillip J. Sanchez et al.
JOURNAL OF IMMUNOLOGY (2007)
Interteukin-2 therapy of metastatic renal cell carcinoma- Predictors of response
David F. McDermott et al.
SEMINARS IN ONCOLOGY (2006)
A pilot study of the liposomal MUC1 vaccine BLP25 in prostate specific antigen failures after radical prostatectomy
S. A. North et al.
JOURNAL OF UROLOGY (2006)
In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles
ST Reddy et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Selective stimulation of T cell subsets with antibody-cytokine immune complexes
O Boyman et al.
SCIENCE (2006)
Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know
YF Shi et al.
CELL RESEARCH (2006)
Complement activation and protein adsorption by carbon nanotubes
C Salvador-Morales et al.
MOLECULAR IMMUNOLOGY (2006)
A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA
KJ Ishii et al.
NATURE IMMUNOLOGY (2006)
From the Th1/Th2 paradigm towards a toll-like receptor/T-helper bias
MG Netea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Direct stimulation of human T cells via TLR5 and TLR7/8:: Flagellin and R-848 up-regulate proliferation and IFN-γ production by memory CD4+ T cells
G Caron et al.
JOURNAL OF IMMUNOLOGY (2005)
Hierarchies in cytokine expression profiles for acute and resolving influenza virus-specific CD8+ T cell responses:: Correlation of cytokine profile and TCR avidity
NL La Gruta et al.
JOURNAL OF IMMUNOLOGY (2004)
Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN
CL Ahonen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Vaccine-induced CD4+ T cell responses to MAGE-3 protein in lung cancer patients
D Atanackovic et al.
JOURNAL OF IMMUNOLOGY (2004)
Interleukin-2 is essential for CD4+CD25+ regulatory T cell function
M de la Rosa et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities
J Vollmer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Aluminium compounds for use in vaccines
EB Lindblad
IMMUNOLOGY AND CELL BIOLOGY (2004)
Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways
K Hoebe et al.
NATURE IMMUNOLOGY (2003)
Recent advances in the discovery and delivery of vaccine adjuvants
DT O'Hagan et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells
WW Overwijk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion
S Gillessen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigens
GQ Phan et al.
JOURNAL OF IMMUNOTHERAPY (2003)
Preferential accumulation of antigen-specific effector CD4 T cells at an antigen injection site involves CD62E-dependent migration but not local proliferation
RL Reinhardt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: Impact of HLA class I antigen expression on outcome
JA Sosman et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains
I Babai et al.
VACCINE (2001)
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
L Alexopoulou et al.
NATURE (2001)
Hydrophilic poly(DL-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells
E Walter et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Inducible IL-2 production by dendritic cells revealed by global gene expression analysis
F Granucci et al.
NATURE IMMUNOLOGY (2001)
Molecular mechanisms of B lymphocyte activation by the immune response modifier R-848
GA Bishop et al.
JOURNAL OF IMMUNOLOGY (2000)
Mechanism and function of a newly identified CpG DNA moth in human primary B cells
G Hartmann et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
